Toxicant-Induced Liver Disease Mechanisms

The liver’s central role in detoxification renders it vulnerable to injury by environmental and pharmaceutical toxicants. Hepatocytes metabolise xenobiotics via cytochrome P450 enzymes, producing reactive intermediates that can provoke oxidative stress, mitochondrial dysfunction and lipid peroxidation. Disruption of lipid homeostasis promotes steatosis, which, if unresolved, advances to non-alcoholic steatohepatitis (NASH) through inflammatory signalling and cytokine release. Chronic injury instigates stellate cell activation and extracellular matrix deposition, leading to fibrosis and cirrhosis. Persistent DNA damage and altered cell-cycle control underpin the development of hepatocellular carcinoma. Integrated adverse outcome pathway models now link molecular initiating events—such as receptor activation or DNA adduct formation—to apical endpoints, guiding risk assessment, biomarker discovery and targeted intervention strategies with global relevance for occupational and environmental health.

Research from Nature Portfolio

Recent studies have elucidated the molecular crosstalk between polycyclic pollutants and liver disease progression. For instance, investigations into benzopyrene exposure have revealed that this carcinogen disrupts DNA repair pathways and metabolic gene networks, fostering a cascade from steatosis through non-alcoholic steatohepatitis to hepatocellular carcinoma. Bioinformatic network analyses identified key hub genes involved in stress response and lipid homeostasis, which were validated in both animal models and human tissue. These findings point towards novel therapeutic targets for interrupting the progression of toxicant-induced liver pathology.

Toxicant-Induced Liver Disease Mechanisms publication trend

The graph below shows the total number of articles in toxicant-induced liver disease mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Steatosis: Accumulation of lipids within hepatocytes leading to fatty liver.

Non-alcoholic steatohepatitis (NASH): An inflammatory stage of fatty liver disease characterised by hepatocyte injury and fibrosis.

Hepatocellular carcinoma (HCC): A primary malignant tumour of the liver often arising from chronic liver injury.

Xenobiotic metabolism: Liver enzymatic processes that modify foreign compounds to more water-soluble forms for excretion.

Oxidative stress: Imbalance between reactive oxygen species production and antioxidant defences causing cellular damage.

Adverse outcome pathway (AOP): A structured framework linking molecular events to adverse health outcomes for toxicity prediction.

References

1. Editor’s Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis. Toxicological Sciences (2017).
2. Unraveling the molecular links between benzopyrene exposure, NASH, and HCC: an integrated bioinformatics and experimental study. Scientific Reports (2023).
3. Steatosis and Metabolic Disorders Associated with Synergistic Activation of the CAR/RXR Heterodimer by Pesticides. Cells (2023).
4. Effects of environmental contaminants in water resources on nonalcoholic fatty liver disease. Environment International (2021).
5. Toxicant-Induced Metabolic Alterations in Lipid and Amino Acid Pathways Are Predictive of Acute Liver Toxicity in Rats. International Journal of Molecular Sciences (2020).